# Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products:  Nonclinical Information - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/generally-accepted-scientific-knowledge-in-applications-for-drug-and-biological-products-nonclinical-information/80a1d387-00c7-42b3-90ef-982941cdff8b

> FDA guidance document: Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products:  Nonclinical Information. Issue date: May 24, 2023. Get complete insights and analysis.

---

## Details

- Title: Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products:  Nonclinical Information
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2023-05-24
- Comment Close Date: 2023-07-24
- Last Changed: 2023-05-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-1618">FDA-2023-D-1618</a>

## Related Documents

- [Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-bayesian-methodology-in-clinical-trials-of-drug-and-biological-products-draft-guidance-for-industry/8e9c345e-0994-47b3-8d6c-054f04ed937e)
- [Regulatory Considerations for Prescription Drug Use-Related Software](https://www.globalkeysolutions.net/guidances/guidance-document/regulatory-considerations-for-prescription-drug-use-related-software/91768cc9-a953-4b59-9da8-4726750c15e7)
- [Nonproprietary Naming of Biological Products: Update Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonproprietary-naming-of-biological-products-update-guidance-for-industry/8adaef5a-6903-4e65-ac57-121d51429730)